These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 9506583)
1. Increased serum levels of cartilage oligomeric matrix protein in chronic erosive arthritis in rats. Vingsbo-Lundberg C; Saxne T; Olsson H; Holmdahl R Arthritis Rheum; 1998 Mar; 41(3):544-50. PubMed ID: 9506583 [TBL] [Abstract][Full Text] [Related]
2. Increased serum levels of cartilage oligomeric matrix protein and bone sialoprotein in rats with collagen arthritis. Larsson E; Müssener A; Heinegård D; Klareskog L; Saxne T Br J Rheumatol; 1997 Dec; 36(12):1258-61. PubMed ID: 9448585 [TBL] [Abstract][Full Text] [Related]
3. [Cartilage oligomeric matrix protein (COMP): the role of a non-collagen cartilage matrix protein as a marker of disease activity and joint destruction in patients with rheumatoid arthritis and osteoarthritis]. Marti C; Neidhart M; Gerber T; Hauser N; Michel BA; Häuselmann HJ Z Rheumatol; 1999 Apr; 58(2):79-87. PubMed ID: 10408068 [TBL] [Abstract][Full Text] [Related]
5. Serum concentrations of cartilage oligomeric matrix protein, fibrinogen and hyaluronan distinguish inflammation and cartilage destruction in experimental arthritis in rats. Larsson E; Erlandsson Harris H; Lorentzen JC; Larsson A; Månsson B; Klareskog L; Saxne T Rheumatology (Oxford); 2002 Sep; 41(9):996-1000. PubMed ID: 12209032 [TBL] [Abstract][Full Text] [Related]
6. Increased serum concentrations of cartilage oligomeric matrix protein. A prognostic marker in early rheumatoid arthritis. Forslind K; Eberhardt K; Jonsson A; Saxne T Br J Rheumatol; 1992 Sep; 31(9):593-8. PubMed ID: 1525624 [TBL] [Abstract][Full Text] [Related]
7. Corticosteroid treatment of experimental arthritis retards cartilage destruction as determined by histology and serum COMP. Larsson E; Erlandsson Harris H; Larsson A; Månsson B; Saxne T; Klareskog L Rheumatology (Oxford); 2004 Apr; 43(4):428-34. PubMed ID: 15024132 [TBL] [Abstract][Full Text] [Related]
8. Serum levels of cartilage oligomeric matrix protein. A predicting factor and a valuable parameter for disease management in rheumatoid arthritis. Skoumal M; Kolarz G; Klingler A Scand J Rheumatol; 2003; 32(3):156-61. PubMed ID: 12892252 [TBL] [Abstract][Full Text] [Related]
9. Chronicity of pristane-induced arthritis in rats is controlled by genes on chromosome 14. Wester L; Olofsson P; Ibrahim SM; Holmdahl R J Autoimmun; 2003 Dec; 21(4):305-13. PubMed ID: 14624754 [TBL] [Abstract][Full Text] [Related]
10. Small fragments of cartilage oligomeric matrix protein in synovial fluid and serum as markers for cartilage degradation. Neidhart M; Hauser N; Paulsson M; DiCesare PE; Michel BA; Häuselmann HJ Br J Rheumatol; 1997 Nov; 36(11):1151-60. PubMed ID: 9402858 [TBL] [Abstract][Full Text] [Related]
11. Cartilage oligomeric matrix protein: a novel marker of cartilage turnover detectable in synovial fluid and blood. Saxne T; Heinegård D Br J Rheumatol; 1992 Sep; 31(9):583-91. PubMed ID: 1381980 [TBL] [Abstract][Full Text] [Related]
12. Cartilage oligomeric matrix protein induction of chronic arthritis in mice. Carlsen S; Nandakumar KS; Bäcklund J; Holmberg J; Hultqvist M; Vestberg M; Holmdahl R Arthritis Rheum; 2008 Jul; 58(7):2000-11. PubMed ID: 18576344 [TBL] [Abstract][Full Text] [Related]
13. Clinical significance of decreased serum concentration of cartilage oligomeric matrix protein in systemic juvenile idiopathic arthritis. Urakami T; Manki A; Inoue T; Oda M; Tanaka H; Morishima T J Rheumatol; 2006 May; 33(5):996-1000. PubMed ID: 16652429 [TBL] [Abstract][Full Text] [Related]
14. Cartilage oligomeric matrix protein deficiency promotes early onset and the chronic development of collagen-induced arthritis. Geng H; Carlsen S; Nandakumar KS; Holmdahl R; Aspberg A; Oldberg A; Mattsson R Arthritis Res Ther; 2008; 10(6):R134. PubMed ID: 19014566 [TBL] [Abstract][Full Text] [Related]
15. Serum levels of cartilage oligomeric matrix protein (COMP) increase temporarily after physical exercise in patients with knee osteoarthritis. Andersson ML; Thorstensson CA; Roos EM; Petersson IF; Heinegård D; Saxne T BMC Musculoskelet Disord; 2006 Dec; 7():98. PubMed ID: 17156423 [TBL] [Abstract][Full Text] [Related]
16. Inhibitory effects of leflunomide therapy on the activity of matrixmetalloproteinase-9 and the release of cartilage oligomeric matrix protein in patients with rheumatoid arthritis. Kullich WC; Mur E; Aglas F; Niksic F; Czerwenka C Clin Exp Rheumatol; 2006; 24(2):155-60. PubMed ID: 16762150 [TBL] [Abstract][Full Text] [Related]
17. Serum levels of cartilage oligomeric matrix protein (COMP): a rapid decrease in patients with active rheumatoid arthritis undergoing intravenous steroid treatment. Skoumal M; Haberhauer G; Feyertag J; Kittl EM; Bauer K; Dunky A Rheumatol Int; 2006 Sep; 26(11):1001-4. PubMed ID: 16485108 [TBL] [Abstract][Full Text] [Related]
18. Serum COMP-C3b complexes in rheumatic diseases and relation to anti-TNF-α treatment. Happonen KE; Saxne T; Geborek P; Andersson M; Bengtsson AA; Hesselstrand R; Heinegård D; Blom AM Arthritis Res Ther; 2012 Jan; 14(1):R15. PubMed ID: 22264230 [TBL] [Abstract][Full Text] [Related]
19. Improvement of reduced serum cartilage oligomeric matrix protein levels in systemic juvenile idiopathic arthritis patients treated with the anti-interleukin-6 receptor monoclonal antibody tocilizumab. Nakajima S; Naruto T; Miyamae T; Imagawa T; Mori M; Nishimaki S; Yokota S Mod Rheumatol; 2009; 19(1):42-6. PubMed ID: 18726067 [TBL] [Abstract][Full Text] [Related]
20. HLA DRB1* typing and cartilage oligomeric matrix protein (COMP) as predictors of joint destruction in recent-onset rheumatoid arthritis. Wollheim FA; Eberhardt KB; Johnson U; Saxne T Br J Rheumatol; 1997 Aug; 36(8):847-9. PubMed ID: 9291852 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]